Sanofi

About

Sanofi is a healthcare company that provides treatments and the protection of life-saving vaccines.

Bridgewater,New Jersey,United States
10001 - max
https://www.sanofi.com

Highlights

Details

Last Funding Type: Post-IPO Equity
Last Funding Money Raised: €300M
Industries: Health Care,Life Science,Pharmaceutical,Therapeutics
Founded date: Jan 1, 2004
Number Of Employee: 10001 - max
Operating Status: Active
Stock Symbol: nyse:SNY
Legal Name: Sanofi-Aventis U.S. LLC.

Sanofi offers research, development, manufacturing, and marketing of innovative therapeutic solutions. It covers areas such as diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health, and the new G enzyme. Its products include prescriptions and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, vaccines, and other medical products.

The two young groups Sanofi and Synthélabo merged in May 1999 to create a major new pharmaceutical player. Sanofi dates back to 1973 and Synthélabo to 1970. In December 1999, Rhône-Poulenc and Hoechst Marion Roussel formalized their merger with the creation of the Franco-German group Aventis, one of the world’s largest pharmaceutical companies. In August 2004, Sanofi-Synthelabo acquired Aventis. The takeover was finalized on December 31 of that year, giving birth to sanofi-aventis.

On May 6, 2011, sanofi-aventis simplified its name to Sanofi. Sanofi operates in over 100 countries throughout the world.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

€300M $310M

Sanofi has raised a total of €300M $310M in funding over 2 rounds. Their latest funding was raised on Mar 15, 2022 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Mar 15, 2022	Post-IPO Equity	€300M	1	Blackstone Life Sciences	—	Detail
Dec 2, 2014	Post-IPO Equity	$310M	1	Evotec	—	Detail
Jul 12, 2002	IPO	—	—	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

25

14

Sanofi has made 25 investments. Their most recent investment was on Nov 23, 2022, when Livmed's raised €5M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Nov 23, 2022 Livmed's	Seed	€5M	Delivery Service	Yes
Aug 4, 2022 Innovent Biologics	Post-IPO Equity	$2.42B	Biopharma	Yes
Jul 12, 2022 Areteia Therapeutics	Series A	$350M	Biotechnology	—
Jan 10, 2022 Exscientia	Post-IPO Equity	$100M	Artificial Intelligence	Yes
Nov 18, 2021 Owkin	Corporate Round	$180M	Artificial Intelligence	Yes

Investors

Number of Lead Investors

Number of Investors

2

Sanofi is funded by 2 investors. Blackstone Life Sciences and Evotec are the most recent investors.

Investor Name	Lead Investor	Funding Round
Blackstone Life Sciences	Yes	Post-IPO Equity
Evotec	Yes	Post-IPO Equity

Employee Profiles

Number of Employee Profiles

80

Sanofi has 80 current employee profiles, including Board member Suet Lee

Board member

Executive

Executive

Board member

Board member

Exits

Sanofi has had 12 exits. Sanofi most notable exits include Gyroscope Therapeutics , Exscientia

Date	Company Name	Exit Type	Industry
Dec 22, 2021	Gyroscope Therapeutics	M&A	Biotechnology	Detail
Oct 1, 2021	Exscientia	IPO	Artificial Intelligence	Detail
Jul 29, 2021	Icosavax	IPO	Biotechnology	Detail
Oct 9, 2019	BioNTech	IPO	Biopharma	Detail
Jul 17, 2019	Fulcrum Therapeutics	IPO	Biotechnology	Detail

Acquisition

Sanofi has acquired 25 organizations. Their most recent acquisition was Aventis SA on Aug 30, 2004. They acquired Aventis SA for 0.

Date Company Name	Industry	Acquisition Type	Price
Aug 30, 2004 Aventis SA	Biotechnology	acquisition	—	Detail
Sep 24, 2008 Zentiva	Health Care	acquisition	$ 2.60B	Detail
Apr 8, 2009 Medley Farma	Pharmaceutical	acquisition	—	Detail
Apr 15, 2009 BiPar Sciences	Biotechnology	acquisition	$ 500M	Detail
Jul 13, 2009 Merial Limited	Biotechnology	—	—	Detail